Organisation paid for research Program year 2025 Source: CMS Open Payments

West End Dermatology

Neither a doctor nor a teaching hospital

Research payments

$80,497

40 payments

Through program year 2025, West End Dermatology is reported as receiving $80,497 in research payments, across 40 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$297	1
2024	Research	$12	1
2023	Research	$279	4
2022	Research	$752	20
2021	Research	$15,597	2
2020	Research	$55,160	11
2019	Research	$8,400	1

Breakdown

Who paid Research payments · program years 2019–2025

Incyte Corporation $80,188 38 payments
Amgen Inc. $310 2 payments

Studies the money was for Research payments · program years 2019–2025

TRuE AD1-An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis $70,757 13 payments
TRuE AD1 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis $8,400 1 payment
A Phase 3, Double-Blinded, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis $752 20 payments
P2 Moderate-Severe pDLE $297 1 payment
A Phase 3, Double-Blinded, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis $279 4 payments
Ph2 DAX Discoid Lupus DLE OLE $12 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.